Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Hypoxia by EF5 Binding in Gynecologic Cancer

NCT00107445 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00107445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00107445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Hypoxia by EF5 Binding in Gynecologic Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2005
Completion date
Not reported
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary peritoneal cavity cancer, stage i endometrial carcinoma, stage i ovarian epithelial cancer, stage ia cervical cancer, stage ib cervical cancer, stage ii endometrial carcinoma, stage ii ovarian epithelial cancer, stage iia cervical cancer, stage iib cervical cancer, stage iii cervical cancer, stage iii endometrial carcinoma, stage iii ovarian epithelial cancer, stage iv endometrial carcinoma, stage iv ovarian epithelial cancer, stage iva cervical cancer, stage ivb cervical cancer